Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02754362
Title A Toll-like Receptor Agonist as an Adjuvant to Tumor Associated Antigens (TAA) Mixed With Montanide ISA-51 VG With Bevacizumab for Patients With Recurrent Glioblastoma
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors New York University School of Medicine
Indications

glioblastoma

Therapies

Poly ICLC

Bevacizumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.